Topic: treatment

The 2027 McKnight Neurobiology of Brain Disorders Award supports research connecting fundamental neuroscience to brain injury or disease, including mechanisms relevant to diagnosis, prevention and treatment. Awards provide USD 100,000 annually for three years, beginning July 2027. Indirect costs and PI/co-PI salary each have a separate 10% total-award cap. Applicants must be independent investigators at US nonprofit research institutions with at least three years in tenured or tenure-track faculty roles. All co-PIs must qualify. Applications close on 15 October 2026 at 17:00 US Central time.

The winter selection recruits doctoral researchers to investigate cancer mechanisms and improve diagnosis, treatment and prevention. Applications close on 19 October 2026 through the DKFZ online system. Research is interdisciplinary, including experimental and computational approaches. Programme positions awarded through the selection are funded by a DKFZ PhD employment contract for at least three years, approximately equivalent to 65% TVöD E13, with social-security contributions and no tuition fees. Review the recruiting groups, admission requirements and application handbook before submissio

This seminar will focus on the extraordinary shift in migraine research during the last 4 decades with the discovery of the trigeminovascular system (TVS) and it’s major impact on pathophysiology and treatment. Compelling evidence supporting the importance of TVS, cortical spreading depression and parameningeal inflammation will be explored as will the implications of newly discovered microvascular channels within the meninges on an attack.